So when I came across the chapter on coffee and neurodegenerative diseases in Revi's book, it got my full attention.

The Alzheimer's data

Let me give you the headline numbers because I think they matter.

Several long-term epidemiological studies have found that regular coffee consumption is associated with a significantly lower risk of developing Alzheimer's disease. The range across studies varies — some report a 25% reduction, others as high as 65% — but the direction is consistent. Coffee drinkers develop Alzheimer's at lower rates than non-drinkers.

One particularly compelling study followed participants in Finland for more than 20 years. Those who drank 3 to 5 cups of coffee per day during their midlife years had the lowest risk of developing dementia later. Twenty years of follow-up data. That's not a weekend study.

What about Parkinson's?

The Parkinson's research is, if anything, even more consistent. Multiple meta-analyses have found a significantly reduced risk of PD among regular coffee drinkers. Ko et al. (2023) showed that habitual coffee consumption lowers the odds of developing PD later in life. And here's the key distinction — for Parkinson's, caffeine appears to be the primary protective agent. The benefit is stronger with caffeinated coffee than with decaf.

That's different from the liver and diabetes research, where decaf retains most of the benefit. With Parkinson's, caffeine itself seems to be doing much of the work. Cunha (2005) demonstrated that caffeine's blockade of adenosine A2A receptors has direct neuroprotective activity relevant to Parkinson's disease, protecting the dopaminergic neurons that PD destroys.

How does coffee protect the brain?

There are several possible mechanisms, and Revi lays them out clearly.

Caffeine's adenosine receptor blockade. Caffeine blocks adenosine A2A receptors in the brain (Carman 2011, Ferré 1997). Blocking these receptors reduces neuroinflammation — the chronic low-grade inflammation in the brain that contributes to neurodegenerative diseases. Think of it as caffeine turning down the volume on an inflammatory signal that, over decades, damages brain tissue.

Antioxidant activity. Those chlorogenic acids we keep coming back to don't just work in the liver. Kumar (2018) demonstrated that chlorogenic acids and their metabolites cross the blood-brain barrier to exert antioxidant effects in brain tissue. Oxidative stress is a major driver of neuronal damage in both Alzheimer's and Parkinson's.

Trigonelline. This is a compound I hadn't heard much about before reading the book. Trigonelline has shown neuroprotective properties in laboratory studies, and it's found in real quantities in coffee — particularly in lighter roasts, where it's better preserved. It's one of those compounds that makes you realize how much is going on in coffee beyond caffeine.

The genetic factor

One thing I appreciate about Revi's approach is that she doesn't oversimplify. She covers the genetics of caffeine metabolism, which matters here.

There's a gene called CYP1A2 that determines how quickly your body processes caffeine. Some people are fast metabolizers — they clear caffeine quickly and can drink coffee all day without sleep problems. Others have a variant that makes them slow metabolizers, leading to prolonged effects from even a single cup.

For the neuroprotective benefit, the speed of caffeine metabolism may influence how much benefit you get. The research is still sorting this out. But it's a reminder that coffee isn't one-size-fits-all, and what's optimal for one person may not be for another.

Why this matters for our community

You might be wondering why I'm covering brain health in a liver disease blog. Here's why.

First, hepatic encephalopathy — the cognitive fog, confusion, and disorientation that can occur with advanced liver disease — is a brain problem caused by a liver problem. When your liver can't clear ammonia efficiently, it crosses the blood-brain barrier and becomes toxic to the central nervous system. This affects 30 to 45% of people with cirrhosis, and it's something I think about. Now, Revi's book doesn't cover this directly, but I went looking and found a 2022 study by Guth et al. that caught my attention. In a rat model of hepatic encephalopathy, caffeine increased the activity of urea cycle enzymes — the very pathway that breaks down ammonia — and the caffeine-treated animals maintained near-normal neurological function while the untreated group developed grade II-III encephalopathy. That's not subtle. It suggests caffeine may be supporting the exact metabolic process that HE disrupts. I'm not drawing clinical conclusions from one animal study, but for our community, this is a thread worth watching.

Second, we're an aging community. Many people manage fatty liver disease for decades. As we age, the risk of neurodegenerative diseases goes up for everyone. If our daily coffee habit is offering some protection against that risk, it's worth knowing about.

Third, the overlap of chronic diseases is real. It's worth noting that some researchers now refer to Alzheimer's as 'Type 3 diabetes' because of the strong links between insulin resistance in the brain and cognitive decline. For our community, that connection is especially relevant, since insulin resistance is the same metabolic driver behind steatotic liver disease. This means the very condition damaging your liver may also be increasing your Alzheimer's risk, and coffee appears to work against both. When you're managing cirrhosis, or cancer, or diabetes, it's easy to focus narrowly. But our bodies don't compartmentalize diseases. Something that's good for your liver, good for your metabolism, and good for your brain — that's a rare overlapping benefit, and coffee appears to deliver all three.

The practical takeaway

Based on the research Revi compiles, the neuroprotective benefit of coffee is strongest at 3 to 5 cups per day. The Parkinson's benefit specifically requires caffeine, so that's one area where decaf doesn't fully substitute. But the Alzheimer's protection appears to involve both caffeine and the polyphenol compounds, so decaf still contributes.

I'm not telling anyone to start drinking five cups of coffee because of one chapter in a book. But I'm saying that if you're already a coffee drinker and you've been worried about the habit, this research should ease your mind — in more ways than one.

Part 4 of an 8-part series on coffee and health. Next: the key compounds in coffee — chlorogenic acids, caffeine, and trigonelline — and why they matter.

If you haven't joined us yet, visit the Fatty Liver Foundation at fattyliverfoundation.org and sign up for our community. Knowledge is power, and community is how we use it.

Next in the series: What's actually in your coffee? The compounds that matter →